Zidovudine (AZT) treatment suppresses granulocyte-monocyte colony stimulating factor receptor type alpha (GM-CSFRα) gene expression in murine bone marrow cells

Medicine & Life Sciences

• Granulocyte Colony-Stimulating Factor Receptors 100%
• Zidovudine 77%
• Granulocyte-Macrophage Progenitor Cells 60%
• Bone Marrow Cells 60%
• Monocytes 53%
• Interleukin-3 Receptors 51%
• Erythroid Precursor Cells 40%
• Gene Expression 38%
• Interleukin-3 37%
• Granulocyte-Macrophage Colony-Stimulating Factor 33%
• Granulocytes 31%
• Granulocyte-Macrophage Colony-Stimulating Factor Receptors 24%
• Glyceraldehyde-3-Phosphate Dehydrogenases 20%
• Erythropoietin 16%
• Neutropenia 16%
• Stem Cells 11%
• Therapeutics 10%
• Messenger RNA 9%
• Growth 8%
• In Vitro Techniques 6%

Chemical Compounds

• Zidovudine 96%
• Colony Stimulating Factor 95%
• Erythropoietin 45%
• Glyceraldehyde 3-Phosphate 42%